TAK1 promotes ovarian cancer aggressiveness through activation of NF-kB pathway
Ovarian cancer is one of the most deadly female malignancies. Despite advances in the treatment of ovarian cancer for the past decade, the cure rate of this disease is moderately improved. Emerging evidence suggests the molecular personalized therapeutic approach become popular for human cancer trea...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Language: | English |
| Published: |
The University of Hong Kong (Pokfulam, Hong Kong)
2014
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10722/193410 |